Fresenius Medical Care | FME - Net Income


Fresenius Medical Care reported EUR218.38M in Net Income for its fiscal quarter ending in June of 2026.





Net Income Change Date
Akzo Nobel EUR 139M 46M Jun/2026
Alcon AG USD 189M 28M Mar/2026
AstraZeneca USD 2.51B 573M Jun/2026
Bayer EUR 219M 2.54B Jun/2026
Beiersdorf EUR 387M 165M Dec/2025
DaVita Healthcare Partners USD 265.4M 67.87M Jun/2026
Demant DKK 1.18B 758M Jun/2026
E.ON EUR 382M 1.85B Jun/2026
Essilor EUR 1.57B 638M Jun/2026
Fresenius EUR 382M 53M Jun/2026
Fresenius Medical Care EUR 218.38M 100.38M Jun/2026
Genmab DKK 303M 250M Jun/2026
Getinge SEK 839M 177M Jun/2026
Givaudan CHF 479M 113M Dec/2025
GlaxoSmithKline GBP 435M 1.3B Jun/2026
GN Store Nord DKK -22M 933M Jun/2026
GRIFOLS EUR 154M 81M Jun/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Lonza CHF 426M 119M Jun/2025
Merck EUR 490M 169M Jun/2026
Novartis USD 3.26B 108M Jun/2026
Philips EUR 384M 233M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
RWE EUR 1.54B 1.52B Jun/2026
Sanofi EUR 343M 1.27B Jun/2026
SAP EUR 2.21B 277M Jun/2026
Smith & Nephew USD 303M 10M Jun/2026